EOLS
Price
$6.73
Change
+$0.33 (+5.16%)
Updated
Aug 15 closing price
Capitalization
435.33M
86 days until earnings call
RDHL
Price
$1.36
Change
-$0.05 (-3.55%)
Updated
Aug 15 closing price
Capitalization
3.12M
Interact to see
Advertisement

EOLS vs RDHL

Header iconEOLS vs RDHL Comparison
Open Charts EOLS vs RDHLBanner chart's image
Evolus
Price$6.73
Change+$0.33 (+5.16%)
Volume$1.07M
Capitalization435.33M
Redhill Biopharma
Price$1.36
Change-$0.05 (-3.55%)
Volume$27.09K
Capitalization3.12M
EOLS vs RDHL Comparison Chart in %
Loading...
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EOLS vs. RDHL commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EOLS is a Hold and RDHL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (EOLS: $6.73 vs. RDHL: $1.36)
Brand notoriety: EOLS and RDHL are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: EOLS: 74% vs. RDHL: 4%
Market capitalization -- EOLS: $435.33M vs. RDHL: $3.12M
EOLS [@Pharmaceuticals: Generic] is valued at $435.33M. RDHL’s [@Pharmaceuticals: Generic] market capitalization is $3.12M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EOLS’s FA Score shows that 0 FA rating(s) are green whileRDHL’s FA Score has 0 green FA rating(s).

  • EOLS’s FA Score: 0 green, 5 red.
  • RDHL’s FA Score: 0 green, 5 red.
According to our system of comparison, both EOLS and RDHL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EOLS’s TA Score shows that 4 TA indicator(s) are bullish while RDHL’s TA Score has 5 bullish TA indicator(s).

  • EOLS’s TA Score: 4 bullish, 4 bearish.
  • RDHL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both EOLS and RDHL are a good buy in the short-term.

Price Growth

EOLS (@Pharmaceuticals: Generic) experienced а +14.07% price change this week, while RDHL (@Pharmaceuticals: Generic) price change was +17.24% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Reported Earning Dates

EOLS is expected to report earnings on Nov 11, 2025.

RDHL is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EOLS($435M) has a higher market cap than RDHL($3.12M). EOLS YTD gains are higher at: -39.040 vs. RDHL (-78.100). EOLS has more cash in the bank: 67.9M vs. RDHL (13.3M). RDHL has less debt than EOLS: RDHL (2.28M) vs EOLS (130M).
EOLSRDHLEOLS / RDHL
Capitalization435M3.12M13,933%
EBITDA-30.78MN/A-
Gain YTD-39.040-78.10050%
P/E RatioN/A0.09-
Revenue275MN/A-
Total Cash67.9M13.3M511%
Total Debt130M2.28M5,692%
FUNDAMENTALS RATINGS
EOLS vs RDHL: Fundamental Ratings
EOLS
RDHL
OUTLOOK RATING
1..100
5192
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
91
Overvalued
PROFIT vs RISK RATING
1..100
75100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9596
P/E GROWTH RATING
1..100
10082
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RDHL's Valuation (91) in the Biotechnology industry is in the same range as EOLS (92) in the Pharmaceuticals Major industry. This means that RDHL’s stock grew similarly to EOLS’s over the last 12 months.

EOLS's Profit vs Risk Rating (75) in the Pharmaceuticals Major industry is in the same range as RDHL (100) in the Biotechnology industry. This means that EOLS’s stock grew similarly to RDHL’s over the last 12 months.

EOLS's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as RDHL (100) in the Biotechnology industry. This means that EOLS’s stock grew similarly to RDHL’s over the last 12 months.

EOLS's Price Growth Rating (95) in the Pharmaceuticals Major industry is in the same range as RDHL (96) in the Biotechnology industry. This means that EOLS’s stock grew similarly to RDHL’s over the last 12 months.

RDHL's P/E Growth Rating (82) in the Biotechnology industry is in the same range as EOLS (100) in the Pharmaceuticals Major industry. This means that RDHL’s stock grew similarly to EOLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EOLSRDHL
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 4 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 4 days ago
71%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 4 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FNWB8.180.16
+2.00%
First Northwest Bancorp
TWFG28.490.48
+1.71%
TWFG Inc
CR189.19-1.79
-0.94%
Crane Company
NSP51.12-1.16
-2.22%
Insperity
OTRK0.33-0.04
-11.98%
Ontrak Inc

EOLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EOLS has been loosely correlated with PRGO. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if EOLS jumps, then PRGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EOLS
1D Price
Change %
EOLS100%
+5.16%
PRGO - EOLS
43%
Loosely correlated
-1.43%
AMRX - EOLS
33%
Poorly correlated
+0.64%
LNTH - EOLS
33%
Poorly correlated
-0.53%
ALKS - EOLS
30%
Poorly correlated
+2.80%
AKBA - EOLS
28%
Poorly correlated
-1.22%
More

RDHL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RDHL has been loosely correlated with ORXOY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RDHL jumps, then ORXOY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDHL
1D Price
Change %
RDHL100%
-3.55%
ORXOY - RDHL
38%
Loosely correlated
-4.50%
EOLS - RDHL
24%
Poorly correlated
+5.16%
CPHRF - RDHL
22%
Poorly correlated
-1.06%
SDZNY - RDHL
21%
Poorly correlated
+1.21%
UTHR - RDHL
15%
Poorly correlated
+0.34%
More